<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Helvetica;
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:106%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-link:"Comment Text Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	font-size:10.0pt;
	font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
	{color:#0563C1;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{color:#954F72;
	text-decoration:underline;}
p
	{margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-link:"Comment Subject Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	font-size:10.0pt;
	font-family:"Calibri",sans-serif;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;}
p.MsoRMPane, li.MsoRMPane, div.MsoRMPane
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	line-height:106%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	line-height:106%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	line-height:106%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	line-height:106%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.msonormal0, li.msonormal0, div.msonormal0
	{mso-style-name:msonormal;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.CommentTextChar
	{mso-style-name:"Comment Text Char";
	mso-style-link:"Comment Text";}
span.CommentSubjectChar
	{mso-style-name:"Comment Subject Char";
	mso-style-link:"Comment Subject";
	font-weight:bold;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Segoe UI",sans-serif;}
p.xmsolistparagraph, li.xmsolistparagraph, div.xmsolistparagraph
	{mso-style-name:x_msolistparagraph;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.apple-converted-space
	{mso-style-name:apple-converted-space;}
.MsoChpDefault
	{font-size:10.0pt;
	font-family:"Calibri",sans-serif;}
@page WordSection1
	{size:8.5in 11.0in;
	margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
-->
</style>

</head>

<body lang=EN-US link="#0563C1" vlink="#954F72">

<div class=WordSection1>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><img width=161 height=86
src="/img/logo-dark-notext.svg" align=left hspace=12></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:16.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:16.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:16.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:16.0pt'>Applied Brain Research Signs Joint
Development and Marketing Agreement with Brain Chip Inc.</span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b>Waterloo, Ontario, Canada - February 1, 2016</b> – Applied Brain
Research, Inc. has signed a strategic, joint development and marketing
agreement with BrainChip Inc., a wholly owned subsidiary of Brainchip Holdings
Limited (ASX: BRN), developer of the revolutionary new Spiking Neuron Adaptive
Processor (SNAP) technology that has the ability to learn autonomously, evolve
and associate information just like the human brain.</p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'>Under the terms of the agreement, BrainChip and ABR will jointly,
non-exclusively, promote each other’s products and services to create a
referral relationship, under which each will refer potential customers to the
other party in exchange for the opportunity to enhance each other’s selling
proposition by offering the customers an integrated hardware and software
offering, and increasing the chances of sales success in the emerging
neuromorphic technologies markets.</p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'>“We are excited to undertake this new strategic partnership with ABR,
whose award winning system is explicitly designed for real-world applications,”
said Peter van der Made, Founder and CEO of BrainChip.  </p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'>“They are an excellent partner with deep industry roots that will help
us accelerate our international sales strategy. This cooperative agreement is a
testament to BrainChip’s ongoing efforts to expand marketing and related
value-added services. At the same time, we look forward to utilizing our
extensive experience in the neuromorphic technologies markets to help ABR
expand its business opportunities. This partnership with ABR allows BrainChip
to become part of their eco-system, supplying solutions to the neuromorphic
industry.”</p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'>“The partnership with BrainChip represents a significant opportunity
for our team to work with a breakthrough company,” said Dr. Chris Eliasmith,
Co-founder of Applied Brain Research. “We believe neuromorphic semiconductor
chips will run the next generation of AI systems, and BrainChip’s hardware
technology is a complete development solution for companies entering the
neuromorphic chip market.”</p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal;page-break-after:avoid;background:white'><b><span style='color:black'>About
BrainChip Holdings Limited</span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'>BrainChip Holdings Limited (ASX: BRN), located in Aliso Viejo, CA, has
developed a revolutionary new Spiking Neuron Adaptive Processor (SNAP)
technology that has the ability to learn autonomously, evolve and associate
information just like the human brain. The technology is fast, completely
digital, and consumes very low power, making it feasible to integrate large
networks into Smart phones and devices, something that has never been possible
before. Additional information is available by visiting <a
href="http://www.brainchipinc.com">www.brainchipinc.com</a>.</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b>About Applied Brain Research</b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'>Applied Brain Research (ABR) is an owner and provider of an integrated
technology software platform focused on building the best integrated AI
systems. ABR’s Nengo is a suite of software tools that is used to develop and
build large scale brain models. ABR’s Spaun program is the world's largest
functional brain simulation. ABR also provides a neuromorphic hardware platform
for developing integrated AI systems with the next generation of computer
hardware: inspired by the brain, powerful, and extremely efficient. For more
information, please visit <a href="http://www.appliedbrainresearch.com">www.appliedbrainresearch.com</a>.</p>

<b><span style='font-size:11.0pt;line-height:106%;font-family:"Calibri",sans-serif;
color:black'><br clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal><b><span style='color:black'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span style='color:black'>Company Contact:</span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal;background:white'><span style='color:black'>Peter Suma</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal;background:white'><span style='color:black'>co-CEO &amp; Chairman</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal;background:white'><span style='color:black'>Applied Brain Research Inc.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal;background:white'><span style='color:black'>416-505-8973</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal;background:white'><span style='color:black'>peter.suma@appliedbrainresearch.com</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal;background:white'>&nbsp;</p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal;background:white'><b><span style='color:black'>Forward Looking
Statements </span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='color:black;background:white'>This press release may
contain certain forward-looking statements and information, as defined within
the meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended, and is subject
to the Safe Harbor created by those sections. This material contains statements
about expected future events and/or financial results that are forward-looking
in nature and subject to risks and uncertainties. Such forward-looking statements
by definition involve risks, uncertainties and other factors, which may cause
the actual results, performance or achievements to be materially different from
the statements made herein.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal;background:white'>&nbsp;</p>

</div>

</body>

</html>
